Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
AXGN · against 557 other Healthcare companies listed in US-listed
Ranked #263 of 558 · scores higher than 52% of peers
Bars: peers in each 10-point band of the profitability score82 peers with a profitability score of 20–29, including AXGN · Click a bar to see the companies
Mainly because of its return on assets, return on invested capital and operating margin, which are weaker than most Healthcare peers.
| Metric | AXGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 517 reported | -6.3% | -7.0% | 50% | 33% | |
| Operating marginHigher is better · 479 reported | -5.1% | -2.4% | 48% | 33% | |
| Return on assetsHigher is better · 582 reported | -11.0% | -7.8% | 47% | 33% | |
| Return on equityHigher is better · 531 reported | -18.2% | -19.7% | 51% | Context only | |
| Gross marginHigher is better · 601 reported | 74.6% | 43.9% | 78% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 52.9B USD | 99 | 57 | |
| 1 | 578M USD | 99 | 73 | |
| 256 | 1.2B USD | 30 | 24 | |
| 263 | 201M USD | 29 | 24 | |
| 263 | 782M USD | 29 | 35 | |
| 263 | 82M USD | 29 | 27 | |
| 263 | 2.9B USD | 29 | 44 | |
| 263 | 487M USD | 29 | 29 | |
| 263 | 1.8B USD | 29 | 31 | |
| 263 | 464M USD | 29 | 53 | |
| 270 | 1.2B USD | 28 | 36 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score